California Public Employees Retirement System’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-68,400
Closed -$1.46M 2669
2021
Q1
$1.46M Sell
68,400
-6,321
-8% -$183K ﹤0.01% 2240
2020
Q4
$2.22M Buy
74,721
+4,921
+7% +$125K ﹤0.01% 1929
2020
Q3
$1.51M Buy
69,800
+1,800
+3% +$41.3K ﹤0.01% 1989
2020
Q2
$1.52M Buy
68,000
+2,573
+4% +$50.2K ﹤0.01% 1953
2020
Q1
$996K Buy
65,427
+20,400
+45% +$365K ﹤0.01% 2017
2019
Q4
$1.03M Buy
45,027
+33,985
+308% +$755K ﹤0.01% 2352
2019
Q3
$238K Buy
+11,042
New +$237K ﹤0.01% 2848

Other funds holding RYTM

California Public Employees Retirement System's RYTM Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2021, closing a stake of 68,400 shares — an estimated $1.46M sold.

California Public Employees Retirement System first reported a position in RYTM in Q3 2019 and held it in 7 quarters. The position peaked at $2.22M in Q4 2020. 105 funds tracked by Wall St. Rank hold RYTM as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Rhythm Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 68,400 Rhythm Pharmaceuticals shares in Q2 2021, an estimated $1.46M.
  • California Public Employees Retirement System first reported a position in Rhythm Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • California Public Employees Retirement System's Rhythm Pharmaceuticals position peaked at $2.22M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.